Dublin, Feb. 26, 2018 -- The "Biochips and Microarrays - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.
This report is an analysis of biochip/microarray markets based on technologies and applications. The report starts with a description of technologies as a basis for estimation of markets. Technologies include array comparative genomic hybridization (CGH), copy number variation (CNV), DNA methylation, ChIP-Chip, RNA splice variants, and microRNA. Separate chapters are devoted to protein biochips/microarrays, microfluidics and nanobiotechnology-based nano-arrays.
Various applications of biochips and microarrays are described throughout the report. Areas of application such as point-of-care, genetic screening, cancer, and diagnosis of infections are included. Separate chapters are devoted to applications in drug discovery and development as well as personalized medicine
The report provides current share of each segment: market size in 2017 and projected value for the years 2022 and 2027. Gene expression has the largest share and is an established market. Share of microarray technologies in other areas will grow with the maximum growth in RNA splice variants followed by epigenetics.
The growth in protein microarrays is somewhat less, partly because it is more mature than the other submarkets and has already shown considerable growth in the past. Impact of next generation sequencing on segments of microarray markets is identified. Customer requirements and unmet needs are described. Markets are also analyzed according to geographical areas.
Brief profiles of companies involved in biochip/microarray technologies are provided. Currently selected 92 companies are included along with listing of 120 collaborations between companies. The text is supplemented by 21 tables, 11 figures and 140 references to literature.
Key Topics Covered:
Executive Summary
1. Introduction
2. Biochip and Microarray Technologies
3. Microfluidics-based Biochips and Microarrays
4. Protein Biochips
5. Nanobiotechnology-based Biochips & Microarrays
6. Biochips & Microarrays for Epigenetics
7. Applications of Microarrays in Drug Discovery & Development
8. Biochips for Biomarkers, Molecular Diagnostics & Personalized
9. Markets
10. Companies
11. References
For more information about this report visit https://www.researchandmarkets.com/research/43ljxm/_biochips_and?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biotechnology


Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts
Sony, TSMC Eye $6.3 Billion Japan Chip Venture for Next-Gen Image Sensors
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Shein Scales Back Vietnam Operations as US Trade Rules Shift
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
DeepSeek to Raise AI API Prices as Demand for New Models Surges 



